ArticleThe journal of pathology. Clinical research2023

Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.

Peter Schraml et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.